Company Comparison
ContralinePioneering male birth control vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | ContralinePioneering male birth control | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Charlottesville, VA | San Diego |
| Founded | 2015 | — |
| Status | Active | Active |
| Last Funding Stage | Series A | Series A |
| Total Funding | $23M | $48M |
| Valuation | — | — |
What They Build
ContralinePioneering male birth control
Biotechnology company developing innovative male contraceptive solutions including non-hormonal birth control methods.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
ContralinePioneering male birth control
AI Therapeutics
No investors listed.
Sector Overlap
Both ContralinePioneering male birth control and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.